Inventor · disambiguated record
Tan Ren
Also filed as: REN TAN
7 granted patents·4 pending applications·24 citations·filing 2002–2013
80Inventor score
Top patents by PatentIndex Score
11 records- 0183US8598353B2Benzazole derivatives, compositions, and methods of use as β-secretase inhibitorsMJALLI ADNAN M M·Filed 2010·Granted Dec 3, 2013·6 cites·14 claims
- 0283US7893267B2Benzazole derivatives, compositions, and methods of use as β-secretase inhibitorsHIGH POINT PHARMACEUTICALS LLC·Filed 2006·Granted Feb 22, 2011·6 cites·8 claims
- 0381US8450354B2Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as β-secretase inhibitorsMJALLI ADNAN M M·Filed 2011·Granted May 28, 2013·7 cites·22 claims
- 0472US8946259B2Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitorsHIGH POINT PHARMACEUTICALS LLC·Filed 2013·Granted Feb 3, 2015·1 cites·3 claims
- 0568US6933303B2Heteroaryl-fused nitrogen heterocycles as therapeutic agentsTRANSTECH PHARMA INC·Filed 2002·Granted Aug 23, 2005·4 cites·13 claims
- 0657US2009247536A1Bissulfonamide Compounds As Agonists Of GalR1, Compositions, And Methods Of UseMJALLI ADNAN M M·Filed 2009·Application pending·0 cites
- 0752US2005096335A1Heteroaryl - fused nitrogen heterocycles as therapeutic agentsFiled 2004·Application pending·0 cites
- 0849US7582673B2Bissulfonamide compounds as agonists of GalR1, compositions, and methods of useHIGH POINT PHARMACEUTICALS LLC·Filed 2005·Granted Sep 1, 2009·0 cites·53 claims
- 0942US2004186151A1Substituted azole derivatives as therapeutic agentsFiled 2004·Application pending·0 cites
- 1039US8350039B2Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitorsHIGH POINT PHARMACEUTICALS LLC·Filed 2011·Granted Jan 8, 2013·0 cites·17 claims
- 1138US2012101093A1Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitorsMJALLI ADNAN M M·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →